EXANE DERIVATIVES - DYNATRACE INC ownership

DYNATRACE INC's ticker is DT and the CUSIP is 268150109. A total of 375 filers reported holding DYNATRACE INC in Q2 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.5%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of DYNATRACE INC
ValueSharesWeighting
Q2 2022$57,886,000
-16.3%
1,4680.0%0.03%
+73.7%
Q1 2022$69,139,000
+4144.3%
1,468
+5337.0%
0.02%
Q4 2021$1,629,000
-98.2%
27
-97.9%
0.00%
-100.0%
Q3 2021$92,825,000
+34.5%
1,308
+15.2%
0.02%
+37.5%
Q2 2021$69,006,000
+6122.4%
1,135
+4834.8%
0.02%
Q1 2021$1,109,000230.00%
Other shareholders
DYNATRACE INC shareholders Q2 2022
NameSharesValueWeighting ↓
THOMA BRAVO, L.P. 84,298,270$3,647,586,00066.81%
Providence Equity Partners L.L.C. 633,145$27,396,00019.13%
HOWARD HUGHES MEDICAL INSTITUTE 1,292,413$55,923,00013.09%
HMI Capital Management, L.P. 5,937,320$256,908,00010.34%
Shannon River Fund Management LLC 1,923,770$83,242,0007.82%
Cota Capital Management, LLC 663,107$28,693,0007.56%
Keenan Capital, LLC 1,006,123$43,535,0007.05%
UNTITLED INVESTMENTS LP 634,341$27,448,0006.16%
Dragoneer Investment Group 8,588,555$371,627,0005.56%
Dorsal Capital Management, LP 1,900,000$82,213,0004.76%
View complete list of DYNATRACE INC shareholders